Mathias Hothum
Directeur/Membre du Conseil chez IMMATICS N.V.
Fortune : 4 M $ au 31/05/2024
Profil
Mathias Hothum is currently the Deputy Chairman-Supervisory Board at Heidelberg Pharma AG, Chairman-Supervisory Board at GEUDER AG, Director-Supervisory Board at Apogenix AG, Managing Director at dievini.
Hopp BioTech holding GmbH & Co. KG, Managing Director at dievini Verwaltungs GmbH, Co-Managing Director at TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG, Managing Director & Owner at Hmm Consulting, Non-Executive Director at Immatics NV (starting in 2023), Member-Supervisory Board at CureVac SE, Member-Supervisory Board at Molecular Health GmbH, Member-Supervisory Board at Novaliq GmbH, and Member-Supervisory Board at CureVac NV (since 2015).
He has previously worked as a Non-Executive Director at AC Immune SA, Director at Weinheim 216 GmbH & Co. KG, Director at Joimax GmbH, Co-Managing Director at Drug Delivery Systems Beteiligungs GmbH, and Member-Supervisory Board at Molecular Health, Inc. Dr. Hothum completed his undergraduate degree at the University of Mannheim and holds a doctorate degree from Otto-von-Guericke-Universität Magdeburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMATICS N.V.
0,32% | 31/01/2024 | 329 521 ( 0,32% ) | 4 M $ | 31/05/2024 |
CUREVAC N.V.
0,05% | 15/03/2024 | 106 349 ( 0,05% ) | 413 698 $ | 31/05/2024 |
Postes actifs de Mathias Hothum
| Sociétés | Poste | Début |
|---|---|---|
| HEIDELBERG PHARMA AG | Directeur/Membre du Conseil | 30/07/2015 |
| CUREVAC N.V. | Directeur/Membre du Conseil | 01/08/2015 |
| IMMATICS N.V. | Directeur/Membre du Conseil | 20/06/2023 |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Directeur/Membre du Conseil | - |
| Hmm Consulting | Directeur Général | - |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
 TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Directeur Général | - |
| dievini Verwaltungs GmbH | Directeur Général | - |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Directeur Général | - |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Mathias Hothum
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Mathias Hothum
| University of Mannheim | Undergraduate Degree |
| Otto-von-Guericke-Universität Magdeburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AC IMMUNE SA | Health Technology |
| HEIDELBERG PHARMA AG | Health Technology |
| IMMATICS N.V. | Health Technology |
| CUREVAC N.V. | Health Technology |
| Entreprise privées | 13 |
|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Health Technology |
dievini Hopp BioTech holding GmbH & Co. KG
dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Finance |
GEUDER AG
 GEUDER AG Medical SpecialtiesHealth Technology GEUDER AG manufactures ophthalmic surgical instruments and systems. Its products include eye specula, retractors, foreign body instruments, scissors, forceps, needle holders and sterilization containers and adapters. The company was founded by Hans Geuder, Sr. in 1951 and is headquartered in Heidelberg, Germany. | Health Technology |
Weinheim 216 GmbH & Co. KG
 Weinheim 216 GmbH & Co. KG BiotechnologyHealth Technology Weinheim 216 GmbH & Co. KG operates as a cellular therapy company involving primary human hepatocytes. The company is headquartered in Weinheim, Germany. | Health Technology |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Health Technology |
| dievini Verwaltungs GmbH | |
Molecular Health GmbH
Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Commercial Services |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Technology Services |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Health Technology |
dievini patch Beteiligungs GmbH
 dievini patch Beteiligungs GmbH Financial ConglomeratesFinance dievini patch Beteiligungs GmbH provides investment services. The company is headquartered in Andernach, Germany. | Finance |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Finance |
| Hmm Consulting |
